Market Cap

OncoArendi Therapeutics SA Market Capitalization:

€31.6 Million

EUR as of Jan. 1, 2026

US$37.1 Million

business OncoArendi Therapeutics SA Company Profile

OncoArendi Therapeutics SA Main Stock Listing

FSX: 1B1

Market Capitalization History of OncoArendi Therapeutics SA

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $158.96 B
Vertex Pharmaceuticals Incorporated $115.92 B
CSL Limited $95.75 B
Regeneron Pharmaceuticals, Inc. $82.28 B
Marinomed Biotech AG $70.11 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $968.50 B
Johnson & Johnson $499.57 B
AbbVie $405.28 B
Roche $332.12 B
UnitedHealth Group $304.72 B

Yearly evolution of OncoArendi Therapeutics SA market cap

Date Market Cap YoY Change
Jan. 1, 2026 €31.6 M -18.40%
Jan. 1, 2025 €38.8 M -48.67%
Jan. 1, 2024 €75.5 M 63.06%
Jan. 1, 2023 €46.3 M -59.50%
Jan. 1, 2022 €114.3 M

Market capitalization is calculated from the opening stock price at the beginning of each year.

OncoArendi Therapeutics SA Categories

Poland languages Healthcare languages Biotechnology
Poland Healthcare Poland Biotechnology

Stocks & Indices

OncoArendi Therapeutics SA has the following listings and related stock indices.


Stock: FSX: 1B1

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.